Ayala Pharmaceuticals Valuation
| ADXSDelisted Stock | USD 1.38 0.34 32.69% |
Today, the firm appears to be overvalued. Ayala Pharmaceuticals shows a prevailing Real Value of $0.99 per share. The current price of the firm is $1.38. Our model approximates the value of Ayala Pharmaceuticals from analyzing the firm fundamentals such as return on equity of -41.98, and Current Valuation of (25.1 M) as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Ayala Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Ayala Pharmaceuticals is based on 3 months time horizon. Increasing Ayala Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ayala otc stock is determined by what a typical buyer is willing to pay for full or partial control of Ayala Pharmaceuticals. Since Ayala Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ayala OTC Stock. However, Ayala Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.38 | Real 0.99 | Hype 1.38 | Naive 1.47 |
The intrinsic value of Ayala Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ayala Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ayala Pharmaceuticals helps investors to forecast how Ayala otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ayala Pharmaceuticals more accurately as focusing exclusively on Ayala Pharmaceuticals' fundamentals will not take into account other important factors: Ayala Pharmaceuticals Total Value Analysis
Ayala Pharmaceuticals is presently anticipated to have valuation of (25.1 M) with market capitalization of 247.58 M, debt of 19 K, and cash on hands of 28.15 M. The negative valuation of Ayala Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Ayala Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(25.1 M) | 247.58 M | 19 K | 28.15 M |
Ayala Pharmaceuticals Investor Information
The company recorded a loss per share of 0.33. Ayala Pharmaceuticals had not issued any dividends in recent years. The entity had 1:125 split on the 29th of March 2019. Based on the key indicators related to Ayala Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Ayala Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Ayala Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ayala Pharmaceuticals has an asset utilization ratio of 0.15 percent. This implies that the OTC Stock is making $0.001479 for each dollar of assets. An increasing asset utilization means that Ayala Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Ayala Pharmaceuticals Ownership Allocation
Ayala Pharmaceuticals holds a total of 145.64 Million outstanding shares. Almost 99.89 percent of Ayala Pharmaceuticals outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 0.1 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ayala Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 250 K. Net Loss for the year was (16.24 M) with profit before overhead, payroll, taxes, and interest of 3.24 M.About Ayala Pharmaceuticals Valuation
The otc valuation mechanism determines Ayala Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Ayala Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ayala Pharmaceuticals. We calculate exposure to Ayala Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ayala Pharmaceuticals's related companies.Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes technology antigen delivery products in the United States. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Advaxis operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 14 people.
8 Steps to conduct Ayala Pharmaceuticals' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Ayala Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ayala Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ayala Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ayala Pharmaceuticals' revenue streams: Identify Ayala Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ayala Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ayala Pharmaceuticals' growth potential: Evaluate Ayala Pharmaceuticals' management, business model, and growth potential.
- Determine Ayala Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ayala Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ayala Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Ayala Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Shares Percent Shares Out | 2.19% | |
| Forward Price Earnings | -10.00 | |
| Float Shares | 1.82M | |
| Shares Short Prior Month | 44.99k |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Ayala OTC Stock
If you are still planning to invest in Ayala Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala Pharmaceuticals' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |